The Precision Nutrition New York Study
PNNY
Optimizing Dietary Fiber Eating Patterns to Prevent Obesity and Resulting Metabolic Disorders
2 other identifiers
interventional
15
1 country
1
Brief Summary
Dietary fiber has been shown to have beneficial effects on human health through its impact on microbes present in the gut. However, these effects can vary between individuals, and everyone may not reap the same health benefits by eating the same sources of fiber. Factors predicting how an individual's gut microbes as well as the beneficial metabolites produced by these microbes change in response to different sources of fiber would be helpful in developing precision nutrition approaches that maximize the benefits of dietary fiber. The objective of this study is to evaluate candidate predictors of gut microbiota response to fiber sources from either whole grains or fruits and vegetables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2025
CompletedStudy Start
First participant enrolled
January 13, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJuly 11, 2025
July 1, 2025
9 months
January 6, 2025
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Body weight changes
For each intervention (whole grains \& fruits and vegetables), investigators will measure change in body weight in kg = Post-intervention minus Pre-intervention
3-4 weeks
Body fat percentage changes
For each intervention (whole grains \& fruits and vegetables), investigators will measure change in fat percentage = Post-intervention minus Pre-intervention
3-4 weeks
Secondary Outcomes (2)
Gut microbiome measured by 16S rRNA gene sequencing
3-4 weeks
Fecal short-chain fatty acid concentrations (SCFAs)
3-4 weeks
Study Arms (2)
Experimental: Group A: Whole grains then fruits and vegetables
EXPERIMENTALWhole grain intervention then fruits and vegetables
Experimental: Group B: Fruits and vegetables then whole grains
EXPERIMENTALFruits and vegetables intervention then whole grains
Interventions
TREATMENT 1: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual.
TREATMENT 1: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual.
Eligibility Criteria
You may qualify if:
- Age is between 21-50 years
- BMI is between 25-30. You can check your BMI here: https://www.cdc.gov/bmi/adult-calculator/index.html
- Must be able to have height, weight, waist, and hip circumference, and body composition measured during the study
- Must be able to provide saliva samples.
- Must be able to provide a phone number and email address at which the study investigators can contact for study-related matters.
- Must be able to increase dietary fiber intake to the recommended level following the instructions on the USDA MyPlate website: https://www.myplate.gov/myplate-plan
- Must be able to provide food records of everything consumed (food, beverage, and supplements) on one weekday and one weekend day (example Tuesday, Saturday) every week during the study. This will be done using an online survey.
- Must be able to provide 10 stool samples over 11 weeks of the study duration. 18) Must have stable weight (within ±3% of usual body weight) for the last two months.
- Must be able to to take an online survey to assess recent dietary fiber intake to determine eligibility.
You may not qualify if:
- Electronic medical implant, for example, a pacemaker.
- An existing, UNTREATED, thyroid condition.
- Use of systemic antibiotics (intravenous injection, intramuscular, or oral) within the last 4 months.
- An acute disease at the time of enrollment (Acute disease is defined as the presence of a moderate or severe illness with or without fever).
- A chronic, clinically significant (unresolved, requiring ongoing medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic, or renal functional abnormality.
- Any suspected state of immunosuppression or immunodeficiency including HIV.
- A history of active UNTREATED gastrointestinal disorders or diseases including
- Inflammatory bowel disease (IBD)
- Ulcerative colitis (mild-moderate-severe)
- Crohn's or celiac disease
- Indeterminate colitis
- Irritable bowel syndrome (IBS) (moderate-severe)
- Persistent, infectious gastroenteritis, colitis or gastritis
- Persistent or chronic diarrhea of unknown etiology
- Clostridium difficile infection (recurrent)
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cornell University
Ithaca, New York, 14850, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Colette Strathman
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2025
First Posted
January 16, 2025
Study Start
January 13, 2025
Primary Completion
October 1, 2025
Study Completion
December 31, 2025
Last Updated
July 11, 2025
Record last verified: 2025-07